Pharmacokinetics of Didehydro-LSD (DDH-LSD) Compared With LSD
This study investigates DDH-LSD, a novel LSD-like compound expected to have a shorter duration of action than LSD. In healthy volunteers, pharmacokinetics, safety, and subjective effects, will be assessed and compare with LSD in a controlled cross-over study.
- Status
- recruiting
- Institution
- University Hospital, Basel, Switzerland
- Principal investigator
- Matthias Liechti, Prof.MD
- Start date
- 2026-03-06
- End date
- 2028-07-01
- Registry ID
- NCT07309471
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.